Review 1: "A Rational Design of a Multi-Epitope Vaccine Against SARS-CoV-2 Which Accounts for the Glycan Shield of the Spike Glycoprotein"
This study employs computational approaches to engineer a multi-epitope vaccine that accounts for the Spike protein glycan shield. The claims should be considered reliable, but experimental validation is needed.
Created on
Nov 11, 2020
Published on
Nov 11, 2020
Last released on
Dec 11, 2020
Cite As
Shukla, P., & Gupta, V. (2020). Review 1: “A Rational Design of a Multi-Epitope Vaccine Against SARS-CoV-2 Which Accounts for the Glycan Shield of the Spike Glycoprotein.” Rapid Reviews Infectious Diseases. https://doi.org/10.1162/2e3983f5.5dbeeb74